Synapse News
1 of 17
Triumvira Immunologics, Inc. (Triumvira), a Hamilton-based private, clinical-stage biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, today announced that the U.S. Food…
Contributing to the latest round of Mariner Endosurgery, Bay Area Health Trust shows strategic…
VoxNeuro is excited to announce that the company will receive up to CA$249,000 in research and…
Five professors of the Faculty of Health Sciences have been elected fellows of the Canadian…
For the first time since 2012, McMaster is ranked among the top 75 universities in the world.…
Since it was conceived, Versant Ventures has provided enabling support for the design and launch of an independent new venture capital and growth equity investment firm dedicated to the medtech sector. Today…
Thank you again to all who participated in the inaugural Future of Health Summit 2019 presented by Hamilton Health Sciences. HHS would also like to thank the delegates who provided their valuable feedback. We…
Proposed Ontario Health Teams will transform how local care is provided under sweeping changes…
Hamilton and area voices will play a key role in the second annual gathering, writes Keanin…